日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

使用 elexacaftor/tezacaftor/ivacaftor 治疗囊性纤维化患者可长期降低炎症水平

期刊:Annals of the American Thoracic Society
影响因子:5.4
doi:10.1513/AnnalsATS.202507-817OC
Sagel, Scott D; Poore, T Spencer; Wagner, Brandie D; Xie, Jing; Heltshe, Sonya L; Cross, Mary; Bratcher, Preston E; Taylor-Cousar, Jennifer L; Wilson, Alexandra; McBennett, Kimberly; Morgan, Sarah J; Singh, Pradeep K; Nichols, David P; Kelly, Andrea; Solomon, George M
炎症/感染
炎症
发表日期：2026
文献求助 收藏

Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor Proliferation.

优化的单硫醇硫氧还蛋白衍生物（ORP100S）在体外和体内可保护细胞免受辐射和化学毒性损伤，且不促进肿瘤增殖。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202504426
Wu Jian, Wang Xiaobei, Mathews Parker, Jabbar Shaima, Zhang Min, Moskowitz Haim, Duan Wei, Nichols David P, Schaaf George William, Olson John D, Macintyre Andrew N, Bourland J Daniel, Spasojevic Ivan, Chi Jen-Tsan Ashley, Ross Joel, Chao Nelson, Cline J Mark, Heifetz Peter B, Kang Yubin
细胞生物学
发表日期：2025
文献求助 收藏

Home sputum collection for Aspergillus fumigatus detection in adults with cystic fibrosis

囊性纤维化成人患者居家痰液采集检测烟曲霉

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00272-2025
Hong, Gina; Walsh, Joanna; Koshy, Allen; Hsu, Jesse Y; O'Dea, Anna L; Vesely, Elisa M; Memon, Warda; Dezube, Rebecca H; Goss, Christopher H; Goss, Louisa B; Greene, Alicia; Gross, Jane E; Wilson, Alexandra; Nichols, David P; Zhang, Sean X; Cramer, Robert A
发表日期：2025
文献求助 收藏

Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis

Elexacaftor/Tezacaftor/Ivacaftor 可显著减少囊性纤维化中的烟曲霉

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202406-1128RL
Morgan, Sarah J; Nichols, David P; Ni, Windy; Hong, Gina; Salipante, Stephen J; Solomon, George M; Rowe, Steven M; Clancy, John P; Cramer, Robert A; Singh, Pradeep K
发表日期：2024
文献求助 收藏

Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment

经过 3.5 年的治疗，Elexacaftor/tezacaftor/ivacaftor 对囊性纤维化感染的疗效得以维持，但并未增强。

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI184171
Morgan, Sarah J; Coulter, Ellis; Betts, Hannah L; Solomon, George M; Clancy, John P; Rowe, Steven M; Nichols, David P; Singh, Pradeep K
炎症/感染
发表日期：2024
文献求助 收藏

Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study

囊性纤维化患者非结核分枝杆菌感染的前瞻性评估：PREDICT 研究的设计

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2023.08.007
Martiniano, Stacey L; Caceres, Silvia M; Poch, Katie; Rysavy, Noel M; Lovell, Valerie K; Armantrout, Emily; Jones, Marion; Anthony, Margaret; Keck, Allison; Nichols, David P; Vandalfsen, Jill M; Sagel, Scott D; Wagner, Brandie; Xie, Jing; Weaver, Katie; Heltshe, Sonya L; Daley, Charles L; Davidson, Rebecca M; Nick, Jerry A
炎症/感染
RED
发表日期：2024
文献求助 收藏

Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis

依来卡夫托/替扎卡夫托/伊伐卡夫托对囊性纤维化患者黏液和黏液纤毛清除的影响

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2023.10.010
Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Mogayzel, Peter; Laube, Beth L; Boitet, Evan R; Harris, Elex S; Ceppe, Agathe; Edwards, Lloyd J; Zeman, Kirby; Wu, Jihong; Esther, Charles R Jr; Nichols, David P; Bennett, William D; Rowe, Steven M
发表日期：2024
文献求助 收藏

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

停用高渗盐水或重组人脱氧核糖核酸酶对接受依来卡托/替扎卡托/伊伐卡托治疗的囊性纤维化患者黏液纤毛清除功能的影响：SIMPLIFY-MCC 研究

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2024.02.003
Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Laube, Beth L; Mogayzel, Peter; Ceppe, Agathe; Wu, Jihong; Zeman, Kirby; Rowe, Steven M; Nichols, David P; Gifford, Alex H; Bennett, William D; Mayer-Hamblett, Nicole
MPL
LIF
发表日期：2024
文献求助 收藏

Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis

囊性纤维化患者开始使用依来沙卡托/替扎沙卡托/伊伐沙卡托后，临床和功能结果的纵向改善

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e29188
Vijaykumar, Kadambari; Leung, Hui Min; Barrios, Amilcar; Wade, Justin; Hathorne, Heather Y; Nichols, David P; Tearney, Guillermo J; Rowe, Steven M; Solomon, George M
发表日期：2024
文献求助 收藏

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

在接受调节剂治疗的囊性纤维化患者中，停用高渗盐水或重组人脱氧核糖核酸酶（dornase alfa）与继续使用高渗盐水或dornase alfa的疗效比较（SIMPLIFY）：两项平行、多中心、开放标签、随机、对照、非劣效性试验的结果

期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(22)00434-9
Mayer-Hamblett, Nicole; Ratjen, Felix; Russell, Renee; Donaldson, Scott H; Riekert, Kristin A; Sawicki, Gregory S; Odem-Davis, Katherine; Young, Julia K; Rosenbluth, Daniel; Taylor-Cousar, Jennifer L; Goss, Christopher H; Retsch-Bogart, George; Clancy, John Paul; Genatossio, Alan; O'Sullivan, Brian P; Berlinski, Ariel; Millard, Susan L; Omlor, Gregory; Wyatt, Colby A; Moffett, Kathryn; Nichols, David P; Gifford, Alex H
MPL
LIF
发表日期：2023
文献求助 收藏